Hence there is sufficient consensus that the most efficient therapeutic strategy for prion diseases would be based on a combinatory approach to stop the conversion of normal cellular PrPc into the neurotoxic and misfolded PrPSc whilst rescuing neurons from initial synaptic dysfunction and neuroinflammation to later neurodegeneration and cell death. This evidence concerns the gene PRNP and prion disease.